Replies to post #49370 on Biotech Values

[dewophile]

interestingly their data in brain CA showed a strong effect on progression and not just survival

[walk]

NWBT got swiss medic approval based on a phase 1, 19 patient trial compared against historical data. If I'm reading the news correctly. The patients were cherry picked (had to have stable disease) after surgery, chemo and radiation.

I knew swiss medic was a lttle more liberal in thier approval procedures than the FDA, but this has got to be a first.